Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terence Friedlander

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Cell|July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell|October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Cell|July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell|October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Pageof 4